View Clinical Trial (Medical Research Study)

The Effect of Obstructive Sleep Apnea on Medical Outcomes After Gastric Bypass Surgery - NCT00671983-94305(Clinical Trial 218712)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Stanford
State:  
CA
Zip Code: 94305
Conditions: Obesity - Sleep Apnea, Obstructive
Purpose: Obstructive sleep apnea (OSA) is a syndrome characterized by repetitive episodes of airway obstruction during sleep, which result in low oxygen level in the blood and bad sleep quality. Both of these effects are implicated in medical, neurological and cognitive disorders in subjects with OSA. The purpose of this study is to examine how OSA affects medical and neurobehavioral outcomes after gastric bypass surgery for weight loss in morbidly obese patients.
Study summary:
Criteria: Inclusion Criteria:-30 to 65 years of age - Scheduled for Laparoscopic roux-en-Y gastric bypass (RYGB) surgery - Presence or absence of OSA confirmed by polysomnography - Comprehension of spoken and written English Exclusion Criteria:-Major psychiatric, neurological, or neuromuscular disorder - History of untreated thyroid disease - Known diabetes mellitus - History of stroke with or without apparent neurological deficits - Alcohol consumption which exceeds 2 drinks per day and /or drug abuse. - Undergone a sleep study in the past
Study is available at: Stanford University School of Medicine
Stanford, CA 94305
United States

Primary Contact:
Anthony Doufas, MD, PhD
Email: agdoufas@stanford.edu
Phone: (650) 498-7699
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.